News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Daniel Drozd

Articles by Daniel Drozd

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)

ByKathryn Martin,Hope Rugo, MD,Gregory Vidal, MD, PhD,Nina Oestreicher,Deepa Lalla,Gillian Hanson,Daniel Drozd,Kristie Traverso,Dan DiPrimeo,Debu Tripathy, MD

April 18th 2022

Latest Updated Articles

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)
April 18th 2022

Trending on CancerNetwork

Perioperative Apalutamide Shifts Standard in Localized, High-Risk Prostate Cancer

Tocilizumab Supports Outpatient Bispecific Antibody Use in Multiple Myeloma

ASCENT-04 Subgroup Analysis Yields Consistent PFS Benefits in Metastatic TNBC

HC-7366/Belzutifan Exhibits Manageable Safety Profile in Advanced RCC

Adjuvant Atezolizumab Shows Minimal Impact on Functioning/QOL in MIBC